Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.74 USD | -1.58% | -4.78% | -13.52% |
Financials (USD)
Sales 2024 * | 34.65M | Sales 2025 * | 127M | Capitalization | 1.14B |
---|---|---|---|---|---|
Net income 2024 * | -384M | Net income 2025 * | -312M | EV / Sales 2024 * | 18.9 x |
Net cash position 2024 * | 491M | Net cash position 2025 * | 372M | EV / Sales 2025 * | 6.1 x |
P/E ratio 2024 * |
-3
x | P/E ratio 2025 * |
-3.86
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.44% |
Latest transcript on Sage Therapeutics, Inc.
1 day | -1.58% | ||
1 week | -4.78% | ||
Current month | -12.76% | ||
1 month | -17.48% | ||
3 months | -15.81% | ||
6 months | -12.06% | ||
Current year | -13.52% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 17 M€ | -0.46% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 18.74 | -1.58% | 1,004,673 |
24-03-27 | 19.04 | +2.26% | 551,465 |
24-03-26 | 18.62 | -0.37% | 830,173 |
24-03-25 | 18.69 | -2.76% | 530,933 |
24-03-22 | 19.22 | -3.76% | 447,310 |
Delayed Quote Nasdaq, March 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.52% | 1.14B | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |